Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 10, Octobre 2010
Page(s) 861 - 868
Section M/S revues
DOI https://doi.org/10.1051/medsci/20102610861
Publié en ligne 15 octobre 2010
  1. Gupta P, Leroux C, Patterson BK, et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral quasi species between blood and semen. J Infect Dis 2000 ; 182 : 79-87. [Google Scholar]
  2. Le Tortorec A, Dejucq-Rainsford N. HIV infection of the male genital tract - consequences for sexual transmission and reproduction. Int J Androl 2009 ; 32 : 1-12. [Google Scholar]
  3. Paranjpe S, Craigo J, Patterson B, et al. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum Retrovir 2002 ; 18 : 1271-80. [Google Scholar]
  4. Ghosn J, Viard JP, Katlama C, et al. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS 2004 ; 18 : 447-57. [Google Scholar]
  5. Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev 2001 ; 65 : 208-31. [Google Scholar]
  6. Munch J, Rucker E, Standker L, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007 ; 131 : 1059-71. [Google Scholar]
  7. Maher D, Wu X, Schacker T, et al. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci USA 2005 ; 102 : 11504-9. [Google Scholar]
  8. Roan NR, Sowinski S, Munch J, et al. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 2010 ; 285 : 1861-9. [Google Scholar]
  9. Sabatte J, Ceballos A, Raiden S, et al. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol 2007 ; 81 : 13723-34. [Google Scholar]
  10. Martellini JA, Cole AL, Venkataraman N, et al. Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J 2009 ; 23 : 3609-18. [Google Scholar]
  11. Cherrier T, Le Douce V, Redel L, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie II : la réactivation de la latence du VIH-1 et ses implications thérapeutiques. Med Sci (Paris) 2010 ; 26 : 291-5. [Google Scholar]
  12. Schwartz C, Le Douce V, Cherrier T, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie I : la physiologie de la latence du VIH-1. Med Sci (Paris) 2010 ; 26 : 159-63 [Google Scholar]
  13. Estaquier J, Hurtrel B. Sanctuaire du virus de l’immunodéficience humaine et mécanismes d’échappement. Med Sci (Paris) 2008 ; 24 : 1055-60. [Google Scholar]
  14. Cherrier T, Le Douce V, Redel L, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie II : la réactivation de la latence du VIH-1 et ses implications thérapeutiques. Med Sci (Paris) 2010 ; 26 : 291-6. [Google Scholar]
  15. Leruez-Ville M, Dulioust E, Costabliola D, et al. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). AIDS 2002 ; 16 : 486-8. [Google Scholar]
  16. Sheth PM, Kovacs C, Kemal KS, et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 2009 ; 23 : 2050-4. [Google Scholar]
  17. Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008 ; 22 : 1677-9. [Google Scholar]
  18. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N Engl J Med 2000 ; 342 : 921-9. [Google Scholar]
  19. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009 ; 23 : 1397-404. [Google Scholar]
  20. Sturmer M, Doerr HW, Berger A, Gute P. Is transmission of HIV-1 in nonviraemic serodiscordant couples possible? Antivir Ther 2008 ; 13 : 729-32. [Google Scholar]
  21. Wilson DP, Law MG, Grulich AE, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008 ; 372 : 314-20. [Google Scholar]
  22. Legeai C, Auvert B. La circoncision : un espoir de réduction de l’infection à VIH en Afrique australe. Med Sci (Paris) 2008 ; 24 : 499-504. [Google Scholar]
  23. Bujan L, Hollander L, Coudert M, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007 ; 21 : 1909-14. [Google Scholar]
  24. Dulioust E, Du AL, Costagliola D, et al. Semen alterations in HIV-1 infected men. Hum Reprod 2002 ; 17 : 2112-8. [Google Scholar]
  25. Bujan L, Sergerie M, Moinard N, et al. Decreased semen volume and spermatozoa motility in HIV-1 infected patients under antiretroviral treatment. J Androl 2007 ; 28 : 444-52. [Google Scholar]
  26. van Leeuwen E, Wit FW, Repping S, et al. Effects of antiretroviral therapy on semen quality. AIDS 2008 ; 22 : 637-42. [Google Scholar]
  27. Dussaix E, Guetard D, Dauguet C, et al. Spermatozoa as potential carriers of HIV. Res Virol 1993 ; 144 : 487-95. [Google Scholar]
  28. Ceballos A, Remes Lenicov F, Sabatte J, et al. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med 2009 ; 206 : 2717-33. [Google Scholar]
  29. Muciaccia B, Corallini S, Vicini E, et al. HIV-1 viral DNA is present in ejaculated abnormal spermatozoa of seropositive subjects. Hum Reprod 2007 ; 22 : 2868-78. [Google Scholar]
  30. Roulet V, Denis H, Staub C, et al. Human testis in organotypic culture: application for basic or clinical research. Hum Reprod 2006 ; 21 : 1564-75. [Google Scholar]
  31. Roulet V, Satie AP, Ruffault A, et al. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am J Pathol 2006 ; 169 : 2094-103. [Google Scholar]
  32. Le Tortorec A, Le Grand R, Denis H, et al. Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One 2008 ; 3 : e1792. [Google Scholar]
  33. Shehu-Xhilaga M, Kent S, Batten J, et al. The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the postacute stage of infection. Retrovirology 2007 ; 4 : 7. [Google Scholar]
  34. Muciaccia B, Filippini A, Ziparo E, et al. Testicular germ cells of HIV- seropositive asymptomatic men are infected by the virus. J Reprod Immunol 1998 ; 41 : 81-93. [Google Scholar]
  35. Smith DM, Kingery JD, Wong JK, et al. The prostate as a reservoir for HIV-1. AIDS 2004 ; 18 : 1600-2. [Google Scholar]
  36. Le Tortorec A, Satie AP, Denis H, et al. Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology 2008 ; 5 : 119. [Google Scholar]
  37. Kiessling AA, Fitzgerald LM, Zhang D, et al. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retrovir 1998 ; 14 : S33-41. [Google Scholar]
  38. Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999 ; 28 : 1252-9. [Google Scholar]
  39. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998 ; 339 : 1803-9. [Google Scholar]
  40. Vernazza PL, Troiani L, Flepp MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV cohort study. Aids 2000 ; 14 : 117-21. [Google Scholar]
  41. Gunthard HF, Havlir DV, Fiscus S, et al. Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J Infect Dis 2001 ; 183 : 1318-27. [Google Scholar]
  42. Lafeuillade A, Solas C, Halfon P, et al. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials 2002 ; 3 : 27-35. [Google Scholar]
  43. Solas C, Lafeuillade A, Halfon P, et al. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2003 ; 47 : 238-43. [Google Scholar]
  44. Bujan L, Daudin M, Matsuda T, et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. Aids 2004 ; 18 : 757-66. [Google Scholar]
  45. Vernazza P, Daneel S, Schiffer V, et al. The role of compartment penetration in PI-monotherapy: the atazanavir-ritonavir monomaintenance (ATARITMO) trial. Aids 2007 ; 21 : 1309-15. [Google Scholar]
  46. Pasquier CJ, Moinard N, Saune K, et al. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. Aids 2008 ; 22 : 1894-6. [Google Scholar]
  47. Nunnari G, Otero M, Dornadula G, et al. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. Aids 2002 ; 16 : 39-45. [Google Scholar]
  48. Craigo JK, Patterson BK, Paranjpe S, et al. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. AIDS Res Hum Retrovir 2004 ; 20 : 1196-209. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.